Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (651-660 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|November 29, 2023
Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in FinlandHeidi Loponen, Juha Mehtälä, Tero Ylisaukko-Oja, et al.
Ejhaem|February 26, 2024
The use of Ambroxol for the treatment of Gaucher disease: A systematic reviewDiego Agustín Abelleyra Lastoria, Simranjeet Grewal, Derralynn Hughes
Ejhaem|February 26, 2024
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell diseaseMyrthe J van Dijk, Marissa J M Traets, Brigitte A van Oirschot, et al.
Ejhaem|February 26, 2024
Identifying clinical response to daratumumab therapy in relapsed/refractory multiple myeloma using a patient-derived in vitro modelNiels van Nieuwenhuijzen, Marta Cuenca, Leonie Abbink, et al.
Ejhaem|August 21, 2023
Leukaemic cells expressing ETV6::FRK are sensitive to dasatinib in vivoAzusa Mayumi, Toshihiko Imamura, Hideki Yoshida, et al.
Ejhaem|August 21, 2023
Splenic marginal zone lymphoma in Sweden 2000-2020: Increasing rituximab use and better survival in the elderlyHenna-Riikka Junlén, Kristina Sonnevi, Ola Lindén, et al.
Ejhaem|August 21, 2023
Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasiaGhazel Mukhtar, Claire L Shovlin
Ejhaem|August 21, 2023
Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic reviewMohammad O Ali, Hafez M Abdullah, Khaldun Obeidat, et al.
Ejhaem|August 21, 2023
Identification and interpretation of TET2 noncanonical splicing site intronic variants in myeloid neoplasm patientsRiku Das, Zheng Jin Tu, David S Bosler, et al.
Ejhaem|August 21, 2023
Hydroxyurea treatment for adult sickle cell anemia patients in KinshasaPaul Lumbala Kabuyi, Gloire Mbayabo, Mamy Ngole, et al.
Pageof 93

Showing results (651-660 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|November 29, 2023
Real-world experience of novel multiple myeloma treatments in a large, single-center cohort in FinlandHeidi Loponen, Juha Mehtälä, Tero Ylisaukko-Oja, et al.
Ejhaem|February 26, 2024
The use of Ambroxol for the treatment of Gaucher disease: A systematic reviewDiego Agustín Abelleyra Lastoria, Simranjeet Grewal, Derralynn Hughes
Ejhaem|February 26, 2024
A novel composition of endogenous metabolic modulators improves red blood cell properties in sickle cell diseaseMyrthe J van Dijk, Marissa J M Traets, Brigitte A van Oirschot, et al.
Ejhaem|February 26, 2024
Identifying clinical response to daratumumab therapy in relapsed/refractory multiple myeloma using a patient-derived in vitro modelNiels van Nieuwenhuijzen, Marta Cuenca, Leonie Abbink, et al.
Ejhaem|August 21, 2023
Leukaemic cells expressing ETV6::FRK are sensitive to dasatinib in vivoAzusa Mayumi, Toshihiko Imamura, Hideki Yoshida, et al.
Ejhaem|August 21, 2023
Splenic marginal zone lymphoma in Sweden 2000-2020: Increasing rituximab use and better survival in the elderlyHenna-Riikka Junlén, Kristina Sonnevi, Ola Lindén, et al.
Ejhaem|August 21, 2023
Unsupervised machine learning algorithms identify expected haemorrhage relationships but define unexplained coagulation profiles mapping to thrombotic phenotypes in hereditary haemorrhagic telangiectasiaGhazel Mukhtar, Claire L Shovlin
Ejhaem|August 21, 2023
Follow up duration of phase III Multiple Myeloma Clinical Trials: A systematic reviewMohammad O Ali, Hafez M Abdullah, Khaldun Obeidat, et al.
Ejhaem|August 21, 2023
Identification and interpretation of TET2 noncanonical splicing site intronic variants in myeloid neoplasm patientsRiku Das, Zheng Jin Tu, David S Bosler, et al.
Ejhaem|August 21, 2023
Hydroxyurea treatment for adult sickle cell anemia patients in KinshasaPaul Lumbala Kabuyi, Gloire Mbayabo, Mamy Ngole, et al.
Pageof 93